Tag: Pharmaceutical Industry

A product that uses the monograph system doesn't have to be reviewed by the FDA before it goes to store shelves. This helps new OTC drugs get approved much faster, especially if they have an active ingredient of a product that is already on the market, like cough syrup. (AP Photo/The Press of Atlantic City, Michael Ein)

Congress plots overhaul of over-the-counter drug rules

Robert King · September 18, 2017 4:01 am

A judge revoked Shkreli's $5 million bond Wednesday. (AP Photo/Seth Wenig)

Martin Shkreli off to jail after bail revoked over Hillary Clinton hair bounty

Diana Stancy Correll, Daniel Chaitin · September 13, 2017 10:18 pm

The fact remains that Americans have access to more drugs earlier than anywhere else in the world, life-saving innovations that will only multiply and become more affordable in a robust market. (AP Photo/Paul Sakuma, File)

Beltway Confidential

Pharmaceutical drugs will only become more affordable thanks to innovation — unless regulations stifle them

April Ponnuru · September 11, 2017 3:53 pm

Lobbyists are on track to spend more money this year than any year since 2010.

Lobbying money spikes under President Trump

Washington Examiner · September 11, 2017 4:01 am

While some people are frightened by the prospect of 3D-printed guns -- including, perhaps, some of the judges in the lower courts here -- that is no reason to allow the government to shut down speech about such guns without ensuring that the restrictions comport with the strictures of the First Amendment.

Files for 3D printed guns are free speech too

Washington Examiner Staff · September 11, 2017 4:01 am

Sen. Claire McCaskill, D-Mo., announces her findings from an investigation into opioid prescriptions, Wednesday, Sept. 6, 2017, on Capitol Hill in Washington. (AP Photo/Jacquelyn Martin)

Sen. Claire McCaskill finds Insys inappropriately pushed opioid to patients

Kimberly Leonard · September 6, 2017 8:35 pm

On Wednesday, the Food and Drug Administration approved the first gene therapy in the U.S. called Kymriah, which customize a patient's own immune cells to fight a type of leukemia through a therapy called CAR-T. The drug's maker, Novartis, plans to sell the treatment for $475,000 for the one-time dose. (AP Photo/Andrew Harnik, File)

Revolutionary cancer treatment comes with hefty price tag

Robert King · August 30, 2017 9:25 pm

With Obamacare reform out of the national limelight, for now, Congress should be looking for bold new ideas to make healthcare more affordable. (AP Photo/Patrick Sison)

Beltway Confidential

On prescription drugs, patients must be ‘free to choose’

Casey Given · August 23, 2017 6:30 pm

Mylan has agreed to repay $465 million to the federal government for overbilling for its lifesaving EpiPen allergy antidote. The settlement comes at the end of an investigation that found Mylan avoided paying state Medicaid programs higher rebates for the EpiPen by improperly naming it as a generic medication. (AP Photo/Pablo Martinez Monsivais, File)

Mylan agrees to pay back government $465 million for EpiPen overbilling

Kimberly Leonard · August 17, 2017 8:01 pm

Reps. Elijah Cummings, D-Md., and Peter Welch, D-Vt., sent letters to seven drug makers seeking answers about price hikes for MS drugs. (AP Photo/Pablo Martinez Monsivais)

Democrats accuse multiple sclerosis drugmakers of ‘shadow pricing’

Robert King · August 17, 2017 3:15 pm

Manufacturers did 38 trials for the 22 drugs approved through the FDA's expedited approval process. Of those trials, only 19 were completed within three years. (AP Photo/Gregory Bull)

Speedy drug approvals lacking in follow-up

Robert King · August 16, 2017 8:39 pm

South Carolina is suing the maker of popular painkiller Oxycontin for deceptively marketing the addictive opioid. (AP Photo/Toby Talbot, File)

South Carolina sues Oxycontin maker

Robert King · August 15, 2017 3:31 pm